REGULATORYMarijuana Moment
Nebraska says medical cannabis testing has no established timeline
Nebraska's Medical Cannabis Commission clarified that it has not set a timeline for product testing, acknowledging that the uncertainty creates planning and financial problems for licensed cultivators. The gap shows Oklahoma operators and regulators how testing authority, transport rules and fee design can become supply-chain bottlenecks in a new medical market.
Published Nov 10, 2026
Read the full article at Marijuana Moment#other-state#nebraska#testing#compliance#licensing
Read the original source
Leafy summaries provide industry context. Confirm details with Marijuana Moment.